News & Views | Published:


The origin, evolution and route to metastasis of clear cell RCC

Nature Reviews Nephrologyvolume 14pages538540 (2018) | Download Citation

Three reports from the TRACERx Renal study delineate the precise origin and evolution of clear cell renal cell carcinoma in minute detail. The insights gained from these studies might provide improved disease prognostics and identify novel therapeutic targets.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Mitchell, T. J. et al. Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx Renal. Cell 173, 611–623.e17 (2018).

  2. 2.

    Turajlic, S. et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal. Cell 173, 581–594.e12 (2018).

  3. 3.

    Turajlic, S. et al. Deterministic evolutionary trajectories influence primary tumor growth: TRACERx Renal. Cell 173, 595–610 e11 (2018).

  4. 4.

    Zbar, B. et al. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 327, 721–724 (1987).

  5. 5.

    Latif, F. et al. Identification of the von Hippel–Lindau disease tumor suppressor gene. Science 260, 1317–1320 (1993).

  6. 6.

    Fei, S. S. et al. Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumours. Nat. Commun. 7, 11588 (2016).

  7. 7.

    Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43–49 (2013).

  8. 8.

    Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012).

  9. 9.

    Gerlinger, M. et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 46, 225–233 (2014).

  10. 10.

    Pena-Llopis, S. et al. BAP1 loss defines a new class of renal cell carcinoma. Nat. Genet. 44, 751–759 (2012).

Download references


The authors’ work is supported by the Intramural Research Program of the US National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research.

Author information


  1. Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA

    • Christopher J. Ricketts
    •  & W. Marston Linehan


  1. Search for Christopher J. Ricketts in:

  2. Search for W. Marston Linehan in:

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to W. Marston Linehan.

About this article

Publication history



Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing